AFP and hepatocellular carcinoma: We also compared the diagnostic efficiency of HIST1H3G with existing approaches, including AFP and PIVKA-II, in discriminating HCC patients from high-risk individuals with LC and chronic hepatitis using quantitative polymerase chain reaction (qPCR) analysis of plasma samples.